Cost-effectiveness analysis of varicella vaccine as post-exposure prophylaxis in Hong Kong

Scandinavian Journal of Infectious Diseases

Volumn 46, Issue 1, 2014, Pages 27-33

  Chui, Ka Sing ^a   Wu, Hiu Lok ^a   You, Joyce H S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chickenpox; Cost effectiveness analysis; Post exposure prophylaxis; Varicella vaccine

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHICKENPOX; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION TREE; DRUG COST; EXPOSURE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HONG KONG; HOUSEHOLD; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MONTE CARLO METHOD; PEDIATRICS; POST EXPOSURE PROPHYLAXIS; PRESCHOOL CHILD; QUALITY ADJUSTED LIFE YEAR; SCHOOL CHILD; SENSITIVITY ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; FEMALE; HONG KONG; HUMANS; INFANT; MALE; MODELS, STATISTICAL; POST-EXPOSURE PROPHYLAXIS;

EID: 84890921244     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2013.847529     Document Type: Article

References (30)

1. Heininger U, Seward JF. V aricella. Lancet 2006; 3 68: 1365-76
2. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis 1995 ; 172: 706-12
3. Macartney K, McIntyre P. V accines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Acute Respiratory Infections Group. Cochrane Database Syst Rev 2008;(3) : C D001833
4. Hong Kong childhood immunisation programme 2012. Hong Kong: Centre for Health Protection;. Available at: Http: //www.chp.gov.hk/en/faq-dtl/9/117/16150. html (accessed 4 November 2012
5. Chan Y C, Kwan Y W, Chow CB, Leung CW. H ospitalisations for varicella among children and adolescents in a tertiary referral hospital in Hong Kong, 2004 to 2008. The Hong Kong Journal of Paediatrics (New Series) 2010;15: 116-25
6. Strutton D R, Stang P E. P rophylaxis against respiratory syncytial virus (RSV), varicella, and pneumococcal infections: Economic-based decision-making. J Pediatr 2003;143 (5 Suppl): S157-62
7. Wolleswinkel-van den Bosch J H, Speets AM, Rumke H C, Gumbs PD, Fortanier SC. The burden of varicella from a parent ' s perspective and its societal impact in the Netherlands: An internet survey. BMC Infect Dis 2011;11: 320
8. Brotons M, Campins M, Mendez L, Juste C, Rodrigo J A, Martinez X, et al. Effectiveness of varicella vaccines as postexposure prophylaxis. Pediatr Infect Dis J 2010;29: 10-3
9. Committee on Infectious Diseases, American Academy of Pediatrics. Varicella vaccine update. Pediatrics 2000;105 (1 Pt 1): 136-41
10. Banz K, Wagenpfeil S, Neiss A, Hammerschmidt T, Wutzler P. The burden of varicella in Germany: Potential risks and economic impact. Eur J Health Econ 2004;5: 46-53
11. Ross AH. M odifi cation of chicken pox in family contacts by administration of gamma globulin. N Engl J Med 1962 ; 267: 369-76
12. Asano Y, Nakayama H, Yazaki T, Kato R, Hirose S. P rotection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics 1977;59: 3-7
13. Arbeter AM, Starr SE, Plotkin SA. V aricella vaccine studies in healthy children and adults. Pediatrics 1986;78: 748-56
14. Salzman M B, Garcia C. P ostexposure varicella vaccination in siblings of children with active varicella. Pediatr Infect Dis J 1998;17: 256-7
15. Watson B, Seward J, Yang A, Witte P, Lutz J, Chan C, et al. Postexposure effectiveness of varicella vaccine. Pediatrics 2000;105(1 Pt 1): 84-8
16. Mor M, Harel L, Kahan E, Amir J. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting - A pilot study. Vaccine 2004;23: 325-8
17. Service guides of Hospital Authority, Hong Kong. Available at: Http: //www.ha.org.hk (accessed 15 April 2013
18. Bilcke J, Ogunjimi B, Marais C, De Smet F, Callens M, Callaert K, et al. The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect 2012;140: 2096-109
19. Brisson M, Edmunds W J. Varicella vaccination in England and Wales: Cost - Utility analysis. Arch Dis Child 2003 ; 88: 862-9
20. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russel LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276: 1253-8
21. Coudeville L, Paree F, Lebrum T, Sailly JC. The value of varicella vaccination in healthy children: Cost - Benefi t analysis of the situation in France. Vaccine 1999;17: 142-51
22. Fornaro P, Gandini F, Marin M, Pedrazzi C, Piccoli P, Tognetti D, et al. Epidemiology and cost analysis of varicella in Italy: Results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases. Pediatr Infect Dis J 1999;18: 414-9
23. Scuffham P, Devlin N, Eberhart-Philips J, Wilson-Salt R. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunization schedule. Soc Sci Med 1999;49: 763-79
24. Beutels P, Clara R, Tormans G, Doorslaer V, Van Damme P. Costs and benefi ts of routine varicella vaccination in German children. J Infect Dis 1996;174(Suppl 3): S335-41
25. Diez Domingo J, Ridao M, Latour J, Ballester A, Morant A. A cost - Benefi t analysis of routine varicella vaccination in Spain. Vaccine 1999;17: 1306-11
26. Lieu T A, Cochi S L, Black S B, Halloran M E, Shinefi eld HR, Holmes SJ, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994;271 : 375-81
27. Shinjoh M, Takahashi T. V aricella zoster exposure on paediatric wards between 2000 and 2007: Safe and effective postexposure prophylaxis with oral aciclovir. J Hosp Infect 2009; 72: 163-8
28. Ferson MJ. V aricella vaccine in post-exposure prophylaxis. Commun Dis Intell 2001;25: 13-5
29. Bate J, Chisholm J, Heath PT, Breuer J, Skinner R, Manley S, et al. PEPtalk: Postexposure prophylaxis against varicella in children with cancer. Arch Dis Child 2011 ; 96: 841-5
30. Unim B, Saulle R, Boccalini S, Taddei C, Ceccherini V, Boccia A, et al. Economic evaluation of varicella vaccination: Results of a systematic review. Hum Vaccin Immunother 2013;9. [Epub ahead of print